· Venture Capital Tracker · investment-strategies · 3 min read
Nua’s $50M Series C Mixes Primary and Secondary — No Split, No Valuation
Peak XV and Filter Capital led a $50 million (~₹472 crore) Series C for Mumbai women’s-wellness brand Nua on September 7, 2026. The company said the print mixes primary capital and secondaries. Inc42 had reported $20–25 million talks. Valuation was not disclosed. ₹500 crore annualised run rate is a company claim.
VCT data record
Funding event facts
Source-backed financing and transaction details. Unknown terms remain undisclosed rather than estimated.
Nua raises $50M Series C led by Peak XV and Filter Capital
Company statement via VCCircle / Entrackr. Mix of primary and secondary; split undisclosed. Valuation not disclosed.
- Event type
- Funding Round
- Event date
- Sep 7, 2026
- Stage / label
- Series C
- Amount
- $50M (~₹472 Cr)
- Confidence
- Company Disclosed
Company / target: Nua
Lead: Peak XV Partners , Filter Capital
Participants: Mirabilis Investment Trust , Footpath Ventures
Sources: vccircle.com entrackr.com
Nua closed a $50 million (~₹472 crore) Series C on September 7, 2026. Peak XV Partners and Filter Capital led. Mirabilis Investment Trust and Footpath Ventures returned. The number that will get copied wrong is treating $50 million as all new equity. The company said the round mixes primary capital and secondaries and did not publish the split. Valuation was not disclosed. Last verified September 7, 2026. Sources: VCCircle (company statement), Inc42, Entrackr (press release).
This is nuawoman.com (Lagom Labs; Mumbai). It is not Nua Surgical and not NuaFund. There is no Peak XV /fund/ page here. Peak XV on this site is Blacksmith’s $45 million Series B.
Five-minute decision
| If you need… | Verdict |
|---|---|
| What happened | Funded. $50M Series C, Sep 7. Peak XV + Filter co-led. |
| Primary vs secondary | Mixed. Split unknown. Inc42: talks were $20–25M; headline grew with secondaries. |
| Valuation | Not disclosed. |
| Traction | Company: ₹100 Cr → ₹500 Cr (~$56M) annualised run rate in 24 months; profitable; 3 million women/girls a month. |
| Whether to diligence | Yes, if you underwrite a profitable India D2C wellness brand. No, if you need a mark or a primary-only number. |
Investigate further when: you can live with a consumer Series C whose headline is larger than the earlier talk range because sellers came along.
Wait or pass when: you need the primary/secondary split, a post-money, or an audited P&L rather than a run-rate claim.
What closed
| Field | Detail |
|---|---|
| Company | Nua / Lagom Labs (nuawoman.com); Mumbai; founded 2017; CEO Ravi Ramachandran; co-founder Abhishek Ramanathan (Inc42) |
| Round | $50M Series C · VCCircle conversion ₹472.4 crore · Sep 7, 2026 |
| Leads | Peak XV Partners; Filter Capital. No /fund/ pages |
| Returning | Mirabilis Investment Trust; Footpath Ventures |
| Secondaries | Partial exits: Kae Capital, Lightbox Ventures, unnamed angels (company) |
| Prior priced stack | $4M Series A, 2019 (Kae / Lightbox). $7.1M pre-Series B, 2021. ₹35 crore pre-Series C, Feb 2025 (Mirabilis; Samir Singh, Shuchi Kothari, SRF Ltd) |
| Total funding | Inc42: crossed $65M. Business Upturn: ~$71.5M. Conflict. Both count the mixed $50M. Do not add $50M as all-primary on top of the older stack. |
| Use of proceeds | Brand, distribution, R&D (company) — primary dollars, not the secondary line |
Do not use Business Upturn’s ₹440 crore conversion. VCCircle printed ₹472.4 crore next to $50 million.
$50M vs the $20–25M talks
Inc42 had Nua in talks for $20–25 million, Peak XV leading. The published print is $50 million because secondaries were added. That is the story, not “India’s biggest women’s-wellness cheque.”
If the primary is still in the earlier range, this is a growth round plus a liquidity event, not a doubling of operating capital. The company did not confirm that math. Do not invent a primary figure.
Capital F’s $17 million debut fund is a pre-seed/seed vehicle for the “female economy.” Nua is a Series C consumer brand. Same reader neighborhood, different job. Capital F is not a disclosed investor here.
What Nua actually sells
Period care, maternity, skincare, intimate care — pads, cramp products, washes, nutrition mixes — plus a Period Tracker app and SecretKeeper chat. Inc42: Amazon, Flipkart, Zepto, plus its own site. Peak XV’s Sakshi Chopra called it the second-largest online player in the category; that is investor language, not a Nielsen extract.
Named competitors on Inc42: Plush, Azah, Pee Safe, Carmesi. Inc42 also notes Pee Safe raised $32 million from OrbiMed earlier in 2026. Different cheque, same shelf.
What remains undisclosed
No valuation. No primary/secondary split. No audited revenue to sit next to the ₹500 crore run rate. Total-funding prints conflict. Do not invent a Peak XV /fund/ page. Do not merge this with Nua Surgical’s €6.5 million Series A.
Related: Nua entity · September 6–7 tape · Capital F · Blacksmith / Peak XV · September hub.
Follow Venture Capital Tracker in Google
Add VCT as a preferred source to make our venture-capital coverage easier to find in Google Search.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
